These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2739202)

  • 1. Fecal immunoglobulin A (IgA) antibodies to Yersinia enterocolitica in mice orally vaccinated and infected.
    Shimono K; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1989 Apr; 51(2):273-7. PubMed ID: 2739202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-resistance to fecal excretion of Yersinia enterocolitica in mice by oral vaccination of killed cells.
    Kaneko K; Hashimoto N
    Infect Immun; 1983 Jun; 40(3):1223-5. PubMed ID: 6852921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine.
    Blanco HM; Lacoste MG; Eliçabe RJ; Di Genaro MS
    Vaccine; 2008 Dec; 26(51):6497-502. PubMed ID: 18835575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecological studies of Yersinia enterocolitica. III. Cross-protection against fecal excretion between Y. enterocolitica serovars 3 and 5.27 in pigs.
    Fukushima H; Ito Y; Saito K; Tsubokura M; Otsuki K
    Vet Microbiol; 1984 Aug; 9(4):383-9. PubMed ID: 6495608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection against fecal excretion of Yersinia enterocolitica and Yersinia pseudotuberculosis in mice by oral vaccination of viable cells.
    Uchida I; Kaneko K; Hashimoto N
    Infect Immun; 1982 May; 36(2):837-40. PubMed ID: 6177641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM, IgG, and IgA antibodies in Yersinia infection.
    Granfors K; Lahesmaa-Rantala K; Toivanen A
    J Infect Dis; 1988 Mar; 157(3):601-2. PubMed ID: 3343532
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of oral and parenteral immunization with killed vaccines on the fecal shedding of mice fed Yersinia enterocolitica.
    Uchida I; Kaneko K; Hashimoto N
    Nihon Juigaku Zasshi; 1982 Jun; 44(3):539-42. PubMed ID: 6215520
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoblot analysis of human IgM, IgG and IgA responses to plasmid-encoded antigens of Yersinia enterocolitica serovar O3.
    Ståhlberg TH; Granfors K; Toivanen A
    J Med Microbiol; 1987 Sep; 24(2):157-63. PubMed ID: 2443704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
    Rastawicki W
    Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of persistent Yersinia antibodies of the IgA class].
    Granfors K; Ogasawara M; Stälberg TH; Toivanen O; Yu D
    Ter Arkh; 1986; 58(7):24-6. PubMed ID: 3764735
    [No Abstract]   [Full Text] [Related]  

  • 11. A new quantitative method for oral vaccination of killed cells and persistence of the vaccination against fecal excretion of Yersinia enterocolitica.
    Yanagisawa J; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1987 Oct; 49(5):795-9. PubMed ID: 3682519
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmid associated antibody production against Yersinia enterocolitica in man.
    Skurnik M; Nurmi T; Granfors K; Koskela M; Tiilikainen AS
    Scand J Infect Dis; 1983; 15(2):173-7. PubMed ID: 6879115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determination of specific IgA-antibodies to Yersinia enterocolitica and their role in enteric infections and their complications.
    Larsen JH; Hartzen SH; Parm M
    Acta Pathol Microbiol Immunol Scand B; 1985 Oct; 93(5):331-9. PubMed ID: 3909736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica.
    Ricciardi ID; Pearson AD; Suckling WG; Klein C
    Infect Immun; 1978 Jul; 21(1):342-4. PubMed ID: 711321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.
    Toivanen A; Lahesmaa-Rantala R; Vuento R; Granfors K
    Ann Rheum Dis; 1987 Dec; 46(12):898-901. PubMed ID: 3426298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis.
    Ståhlberg TH; Heesemann J; Granfors K; Toivanen A
    Ann Rheum Dis; 1989 Jul; 48(7):577-81. PubMed ID: 2774698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of IgA antibodies to lipopolysaccharide in Yersinia-triggered reactive arthritis.
    Granfors K; Ogasawara M; Hill JL; Lahesmaa-Rantala R; Toivanen A; Yu DT
    J Infect Dis; 1989 Jun; 159(6):1142-7. PubMed ID: 2656882
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy.
    Hoogkamp-Korstanje JA; de Koning J; Heesemann J; Festen JJ; Houtman PM; van Oyen PL
    Infection; 1992; 20(2):53-7. PubMed ID: 1582684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal B-cell activation in mice infected by intragastric route with Yersinia enterocolitica O:8.
    Medeiros BM; Ramos OP; Silva EE; Falcão DP
    Adv Exp Med Biol; 2003; 529():147-9. PubMed ID: 12756747
    [No Abstract]   [Full Text] [Related]  

  • 20. An animal model to study serum immunoglobulin response to infection by Yersinia enterocolitica.
    Kono DH; Ogasawara M; Yu DT
    Clin Exp Rheumatol; 1985; 3(2):117-21. PubMed ID: 4017307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.